To assess the suitability of A2A receptor PET for the assessment of changes in the availability of A2A/D2 heterodimeric receptors in neurodegenerative diseases, our group performed dynamic PET studies in a rotenone-based mouse model of Parkinson’s disease with [18F]FESCH. The gene discussed is IGKV2D-29; the disease is Parkinson disease.